When you choose to publish with PLOS, your research makes an impact. Make your work accessible to all, without restrictions, and accelerate scientific discovery with options like preprints and published peer review that make your work more Open.

CALL FOR PAPERS

Primary and Secondary Prevention of Cardiovascular Disease Call for Papers

PLOS ONE

Submit to PLOS ONE, the #1 publisher for research on prevention of cardiovascular disease. Submission deadline has been extended to July 21, 2020.

This call for papers is closed.

Jul 21 2020
SCOPE

Cardiovascular disease is the leading cause of death globally and recent statistics indicate that the decline in mortality observed in the last few decades is stagnating and even reversing in some populations. Robust research and evidence-based preventive strategies are increasingly necessary to reduce the global burden of this disease.

In this Call for Papers, we welcome rigorous research focused on the primary and secondary prevention of cardiovascular disease. A wide range of topics will be considered, such as cardiovascular disease risk factors and determinants (socioeconomic, genetic and lifestyle determinants), cardiovascular risk assessment, cardiac rehabilitation, nutrition, and exercise physiology. In addition, we welcome interdisciplinary research focusing on the influence of comorbidities on the delivery of successful preventive strategies, as well as implementation research on population-wide and individual-based interventions aimed at reducing the risk and socioeconomic impact of cardiovascular disease.

We are in the midst of a revolution in the prevention and management of cardiovascular disease, with the emergence of new drugs and new targets associated with improved cardiovascular outcomes. At the same time, advances in risk assessment, including novel biomarkers, genetics, and noninvasive subclinical atherosclerosis imaging represent major advances that will be implemented more widely in the coming years. Issues related to primary and secondary prevention are becoming increasing complex, and more and more patients are seeking specialized advice on cardiovascular risk assessment and management. This PLOS ONE Collection tackles these bold issues and provides a glimpse into the next frontiers in prevention of cardiovascular disease.
Michael D. Shapiro
Guest Editor
GUEST EDITORS

Michael D. Shapiro
Wake Forest, USA
Webpage

Clara Chow
University of Sydney, Australia
Webpage

Yangfeng Wu
Peking University, China
Webpage

Dominique Hansen
Hasselt University, Belgium
Webpage

Martin O’Flaherty
University of Liverpool, UK
Webpage

Jennifer G. Robinson
University of Iowa, USA
Webpage

Jemma C. Hopewell
University of Oxford, UK
Webpage

Maryam Kavousi
Erasmus University Medical Center, Netherlands
Webpage

Publishing negative data helps move science forward. Another lab shouldn't spend money and time repeating the same experiments only to come out with negative data.
Yvonne Fondufe-Mittendorf
PLOS ONE author
PREVENTION OF CARDIOVASCULAR DISEASE RESEARCH

Over 8,500 PLOS ONE papers have been published related primary and secondary prevention of cardiovascular disease.

43

Days to first decision on average

#1

Publisher for prevention of cardiovascular disease papers

150,000+

Citations on primary and secondary prevention of cardiovascular disease papers

5+ Million

Monthly site visitors

180

Disciplines represented by authors from 200 countries

500+

Interdisciplinary cardiovascular disease prevention papers published

JOURNAL INFORMATION

PLOS ONE publishes primary research across all areas of science, including interdisciplinary research. Research articles are selected for scientific rigor rather than perceived impact.

Email questions to ONEcalls@plos.org

TOP VIEWED ARTICLE
READY TO SUBMIT?

Submit your paper to PLOS ONE to be considered for this Collection.

Mention the Liver Diseases Call for Papers in your cover letter. The Collection will publish November 2020.

This call for papers is closed.

Back to top